相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sex Differences in Brain and Cognition in de novo Parkinson's Disease
Javier Oltra et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine
Marina A. Lynch
FRONTIERS IN AGING NEUROSCIENCE (2022)
Unveiling sex-based differences in Parkinson's disease: a comprehensive meta-analysis of transcriptomic studies
Adolfo Lopez-Cerdan et al.
BIOLOGY OF SEX DIFFERENCES (2022)
The voltage-gated proton channel Hv1 plays a detrimental role in contusion spinal cord injury via extracellular acidosis-mediated neuroinflammation
Yun Li et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Sample size, power and effect size revisited: simplified and practical approaches in pre-clinical, clinical and laboratory studies
Ceyhan Ceran Serdar et al.
BIOCHEMIA MEDICA (2021)
Functions and Mechanisms of the Voltage-Gated Proton Channel Hv1 in Brain and Spinal Cord Injury
Junyun He et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2021)
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
Matthew L. Neal et al.
FASEB JOURNAL (2020)
Dimer interaction in the Hv1 proton channel
Laetitia Mony et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
High-Resolution Respirometry Reveals MPP+ Mitochondrial Toxicity Mechanism in a Cellular Model of Parkinson's Disease
Pierpaolo Risiglione et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Determinants of dopaminergic neuron loss in Parkinson's disease
Dalton James Surmeier
FEBS JOURNAL (2018)
The glycoprotein GPNMB attenuates astrocyte inflammatory responses through the CD44 receptor
Matthew L. Neal et al.
JOURNAL OF NEUROINFLAMMATION (2018)
MPTP-induced parkinsonism: an historical case series (vol 17, pg 300, 2018)
J. Nannekes et al.
LANCET NEUROLOGY (2018)
The Good, the Bad, and the Ugly of ROS: New Insights on Aging and Aging-Related Diseases from Eukaryotic and Prokaryotic Model Organisms
Ana L. Santos et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
MPTP-induced parkinsonism: an historical case series
Jorik Nonnekes et al.
LANCET NEUROLOGY (2018)
Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide
Eric E. Beier et al.
NEUROBIOLOGY OF DISEASE (2017)
Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss
Gelareh Alam et al.
NEUROTOXICOLOGY (2017)
Microglial phenotypes in Parkinson's disease and animal models of the disease
Valerie Joers et al.
PROGRESS IN NEUROBIOLOGY (2017)
Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease
Francesca Siani et al.
FRONTIERS IN NEUROSCIENCE (2017)
Deficiency in the voltage-gated proton channel Hv1 increases M2 polarization of microglia and attenuates brain damage from photothrombotic ischemic stroke
Dai-Shi Tian et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease
Johanna Duda et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase
Lulu Jiang et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs
Taysa Bervian Bassani et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage
Junli Liu et al.
JOURNAL OF NEUROCHEMISTRY (2015)
GENDER-SPECIFIC BRAIN REGIONAL VARIATION OF NEURONS, ENDOGENOUS ESTROGEN, NEUROINFLAMMATION AND GLIAL CELLS DURING ROTENONE-INDUCED MOUSE MODEL OF PARKINSON'S DISEASE
S. Mitra et al.
NEUROSCIENCE (2015)
Evidence for Immune Response, Axonal Dysfunction and Reduced Endocytosis in the Substantia Nigra in Early Stage Parkinson's Disease
Anke A. Dijkstra et al.
PLOS ONE (2015)
Hippocampal ER Stress and Learning Deficits Following Repeated Pyrethroid Exposure
Muhammad M. Hossain et al.
TOXICOLOGICAL SCIENCES (2015)
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
Ye Zhang et al.
JOURNAL OF NEUROSCIENCE (2014)
Voltage-Gated Proton Channel HV1 in Microglia
Long-Jun Wu
NEUROSCIENTIST (2014)
In pursuit of an inhibitory drug for the proton channel
Amaury Pupo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Complex Network-Driven View of Genomic Mechanisms Underlying Parkinson's Disease: Analyses in Dorsal Motor Vagal Nucleus, Locus Coeruleus, and Substantia Nigra
Beatriz Raposo Corradini et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Exposure to the polybrominated diphenyl ether mixture DE-71 damages the nigrostriatal dopamine system: Role of dopamine handling in neurotoxicity
Joshua M. Bradner et al.
EXPERIMENTAL NEUROLOGY (2013)
NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration
Liya Qin et al.
GLIA (2013)
Sustained Interleukin-1β Overexpression Exacerbates Tau Pathology Despite Reduced Amyloid Burden in an Alzheimer's Mouse Model
Simantini Ghosh et al.
JOURNAL OF NEUROSCIENCE (2013)
Coordinated role of voltage-gated sodium channels and the Na+/H+ exchanger in sustaining microglial activation during inflammation
Muhammad M. Hossain et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease
Carmen Noelker et al.
SCIENTIFIC REPORTS (2013)
Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
Jason R. Richardson et al.
NEURAL PLASTICITY (2013)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke
Long-Jun Wu et al.
NATURE NEUROSCIENCE (2012)
A simple magnetic separation method for high-yield isolation of pure primary microglia
Richard Gordon et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
pH regulation and beyond: unanticipated functions for the voltage-gated proton channel, HVCN1
Melania Capasso et al.
TRENDS IN CELL BIOLOGY (2011)
The Promise of Neuroprotective Agents in Parkinson?s Disease
Stacey E. Seidl et al.
Frontiers in Neurology (2011)
Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy
Li Qian et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species
Melania Capasso et al.
NATURE IMMUNOLOGY (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
Voltage-gated proton channel is expressed on phagosomes
Yoshifumi Okochi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The NADPH oxidase inhibitor diphenyleneiodonium is also a potent inhibitor of cholinesterases and the internal Ca2+pump
T. Tazzeo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
A COMPARISON OF MODEL-BASED (2D) AND DESIGN-BASED (3D) STEREOLOGICAL METHODS FOR ESTIMATING CELL NUMBER IN THE SUBSTANTIA NIGRA PARS COMPACTA (SNpc) OF THE C57BL/6J MOUSE
Z. C. Baquet et al.
NEUROSCIENCE (2009)
Hv1 proton channels are required for high-level NADPH oxidase-dependent superoxide production during the phagocyte respiratory burst
I. Scott Ramsey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results
Karl Kieburtz et al.
CLINICAL NEUROPHARMACOLOGY (2008)
Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease
James B. Koprich et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum
R. Pattarini et al.
NEUROSCIENCE (2008)
Inflammation as a causative factor in the aetiology of Parkinson's disease
P. S. Whitton
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Exacerbation of Dopaminergic terminal damage in a mouse model of Parkinson's disease by the g-protein-coupled receptor protease-activated receptor 1
Cecily E. Hamill et al.
MOLECULAR PHARMACOLOGY (2007)
A genomic pathway approach to a complex disease: Axon guidance and parkinson disease
Timothy G. Lesnick et al.
PLOS GENETICS (2007)
Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease
R. Pattarini et al.
NEUROSCIENCE (2007)
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
Maya G. Purisai et al.
NEUROBIOLOGY OF DISEASE (2007)
Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system
Randy L. Hunter et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease
D. C. Duke et al.
NEUROGENETICS (2006)
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease
LB Moran et al.
NEUROGENETICS (2006)
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity:: role of tumor necrosis factor-α
K Sriram et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Minocycline-associated intra-oral soft-tissue pigmentation: clinicopathologic correlations and review
VN LaPorta et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2005)
Safety of doxycycline and minocycline: A systematic review
K Smith et al.
CLINICAL THERAPEUTICS (2005)
Nuclear factor kappa B activation by NADPH oxidases
RA Clark et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2004)
No findings of dental defects in children treated with minocycline
A Cascio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease
E Diguet et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Minocycline enhances MPTP toxicity to dopaminergic neurons
LC Yang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
DC Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Voltage-gated proton channels in microglia
C Eder et al.
PROGRESS IN NEUROBIOLOGY (2001)
分享论文
